SCHEMBL1277643

SCHEMBL1277643

COC(=O)CC1CSC(c2cc3cc(Oc4ccccc4)cc(N)c3[nH]2)=N1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
XDH P47989 2/20 0.36
GCK P35557 1/20 0.32
AKR1B1 P15121 1/20 0.31
GABRA1 P14867 3/20 0.31
GABRR1 P24046 3/20 0.31
GABRA5 P31644 3/20 0.31
GABRB2 P47870 3/20 0.31
GABRA4 P48169 3/20 0.31
SLC6A12 P48065 1/20 0.31
SLC6A13 Q9NSD5 1/20 0.31
GALR3 O60755 1/20 0.31
GAA P10253 1/20 0.31
ABL1 P00519 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1277639 1.00 LMNA (0.37) LMNAMAPTHPGDMAPK1SMN1; SMN2
SCHEMBL1278040 0.91 ABL1 (0.35) ABL1
SCHEMBL1278043 0.91 ABL1 (0.35) ABL1
SCHEMBL13769210 0.90 LMNA (0.30) LMNAMAPTHPGDMAPK1SMN1; SMN2
SCHEMBL1277896 0.89 GCK (0.36) GCK
SCHEMBL1277898 0.89 GCK (0.36) GCK
SCHEMBL1278149 0.89 GABRA1 (0.32) GABRA1GABRR1GABRA5GABRB2GABRA4
SCHEMBL1278145 0.89 GABRA1 (0.32) GABRA1GABRR1GABRA5GABRB2GABRA4
SCHEMBL1277963 0.84 GABRA1 (0.32) XDHGABRA1GABRR1GABRA5GABRB2
SCHEMBL1277701 0.84 GABRA1 (0.32) GABRA1GABRR1GABRA5GABRB2GABRA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8309586-B2 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient LG LIFE SCIENCES LTD. (KR) 2012-11-13 US disclosed
US-20120088760-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT LG CHEM, LTD. (KR) 2012-04-12 US disclosed
US-20100267708-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT LG LIFE SCIENCES LTD. (KR) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088760-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT GCKR, GCK, GALK1 LMNA 3926/4885MAPT 3254/4885HPGD 1608/4885
US-20100267708-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT GCK, GCKR, HK1 LMNA 4171/4885MAPT 2411/4885HPGD 1624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.